What is citalopram used for?

Indications and Usage, quoted from the label by Torrent Pharmaceuticals Limited (ANDA078216). Cross-references to other label sections are left out.

Citalopram tablets are indicated for the treatment of major depressive disorder (MDD) in adults.

Source: DailyMed label, set id 04766f1d-7a69-49ed-8fd3-1a6305505d47, version 23, effective February 4, 2026. NDC 13668-009, one of 68 listings for this product.

Indications and Usage, quoted from the label by ATLANTIC BIOLOGICALS CORP. (ANDA201450). Cross-references to other label sections are left out.

Citalopram oral solution, USP is indicated for the treatment of depression. The efficacy of citalopram oral solution, USP in the treatment of depression was established in 4 to 6 week, controlled trials of outpatients whose diagnosis corresponded most closely to the DSM-III and DSM-III-R category of major depressive disorder (see CLINICAL PHARMACOLOGY). A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. The antidepressant action of citalopram oral solution, USP in hospitalized depressed patients has not been adequately studied. The efficacy of citalopram oral solution, USP in maintaining an antidepressant response for up to 24 weeks following 6 to 8 weeks of acute treatment was demonstrated in two placebo-controlled trials (see CLINICAL PHARMACOLOGY). Nevertheless, the physician who elects to use citalopram oral solution, USP for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.

Source: DailyMed label, set id 2640311d-8b88-4513-9c80-a08390b8142a, version 5, effective October 20, 2026. NDC 17856-0564, one of 6 listings for this product.